Unmet Needs and Emerging Approaches to Management of Polyvascular Disease
Cardiologists share unmet needs and emerging approaches to management of patients with polyvascular disease.
Read More
VOYAGER Trial and DPI in Clinical Practice
Manesh Patel, MD, reviews VOYAGER trial data and expert cardiologists share where they use DPI [dual pathway inhibition] in their practices.
Read More
Access to and Awareness of DPI for Polyvascular Disease
Sahil Parikh, MD, shares how lack of access to or awareness of DPI [dual pathway inhibition] causes many practices and health care providers to face a challenge in treating CAD [coronary artery disease].
Read More
Dual Pathway Inhibition in Coronary Artery Disease
Expert cardiologists provide an overview of dual pathway inhibition, modulation of thrombotic risk and treatment of CAD.
Read More
Risk-Benefit Analysis in Treatment Selection in CAD
Dr Amy Pollak shares her thoughts on risk-benefit analysis when evaluating patients with high thrombotic/bleeding risk and treatment selection.
Read More
Regimen Intensification in Polyvascular Disease
Drs Marc Bonaca and Deepak Bhatt discuss the role of therapy intensification when managing high-risk patients with polyvascular disease.
Read More
Guidelines and Management of Patients With Polyvascular Disease
Expert cardiologists discuss CAD guidelines and approaches to management of patients with polyvascular disease.
Read More
Provider Engagement and Screening
Dr Sahil Parikh and other experts discuss engagement of cardiologists in patients diagnosed with polyvascular disease and challenges in screening patients.
Read More
Overview of Polyvascular Disease and Coronary Artery Disease
Drs Marc Bonaca and Manesh Patel provide an overview of Polyvascular Disease and prevalence of coronary artery disease and peripheral artery disease.
Read More